BioRestorative Therapies Announces Strategic Collaboration with 203 Creates

Partnership to drive brand architecture, go-to-market execution, and global launch of the Company's product portfolio bridging biotechnology and premium skincare

Apr. 7, 2026 at 12:40pm

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life photograph featuring a collection of elegant, minimalist objects arranged on a clean, monochromatic background, conceptually representing the intersection of biotechnology and premium skincare.A premium, science-backed biocosmeceutical brand emerges from the strategic collaboration between BioRestorative Therapies and 203 Creates.Stamford Today

BioRestorative Therapies, Inc., a late-stage clinical regenerative medicine company, has announced a strategic collaboration with 203 Creates, LLC, a Stamford, Connecticut-based firm specializing in the development, marketing, and growth of luxury, premium, and science-backed brands. The collaboration is designed to advance BioRestorative's biocosmeceutical platform by establishing a differentiated brand architecture and executing a comprehensive commercialization strategy.

Why it matters

This partnership represents an important step in BioRestorative's commercialization strategy as the company looks to build a category-leading biocosmeceutical platform. 203 Creates' expertise in brand storytelling, digital infrastructure, and omnichannel go-to-market execution will help translate the company's biologically active formulations into a compelling, category-defining brand positioned at the intersection of biotechnology and premium skincare.

The details

Under the agreement, 203 Creates will lead the strategic development of a consumer-facing platform for BioRestorative's biocosmeceutical products, including brand identity, digital infrastructure, and customer journey design. The collaboration will also support the development of a targeted go-to-market strategy encompassing direct-to-consumer channels, physician and clinic partnerships, and broader global distribution initiatives.

  • The partnership is expected to accelerate BioRestorative's time to market by establishing a clear strategic framework across brand architecture, customer segmentation, and channel strategy.
  • The collaboration is designed to support the introduction of additional product categories and the execution of a global rollout strategy for BioRestorative's biocosmeceutical pipeline.

The players

BioRestorative Therapies, Inc.

A late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, including its biocosmeceutical platform.

203 Creates, LLC

A Stamford, Connecticut-based firm specializing in the development, marketing, and growth of luxury, premium, and science-backed brands.

Crystal Romano

Head of Global Commercialization at BioRestorative Therapies.

Got photos? Submit your photos here. ›

What they’re saying

“Our collaboration with 203 Creates represents an important step in advancing BioRestorative's commercialization strategy as we build a category-leading biocosmeceutical platform.”

— Crystal Romano, Head of Global Commercialization at BioRestorative Therapies

What’s next

The partnership is expected to accelerate BioRestorative's time to market by establishing a clear strategic framework across brand architecture, customer segmentation, and channel strategy, while building the digital and marketing infrastructure necessary to support long-term growth.

The takeaway

This collaboration between BioRestorative Therapies and 203 Creates represents a significant step forward in the development and commercialization of BioRestorative's biocosmeceutical platform. By leveraging 203 Creates' expertise in brand strategy, marketing, and digital execution, BioRestorative aims to establish a differentiated, category-defining brand that bridges the gap between biotechnology and premium skincare.